133 related articles for article (PubMed ID: 2167684)
21. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Agre P; Virshup D; Bennett V
J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
[TBL] [Abstract][Full Text] [Related]
22. Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.
Ivorra MD; Lugnier C; Catret M; Anselmi E; Cortes D; D'Ocon P
Br J Pharmacol; 1993 Jun; 109(2):502-9. PubMed ID: 8358549
[TBL] [Abstract][Full Text] [Related]
23. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone is a potent calmodulin antagonist.
Nokin P; Blondiaux JP; Schaeffer P; Jungbluth L; Lugnier C
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):367-73. PubMed ID: 2544810
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
[TBL] [Abstract][Full Text] [Related]
26. Cyclic nucleotide phosphodiesterase of rat pancreatic islets. Effects of Ca2+, calmodulin and trifluoperazine.
Sugden MC; Ashcroft SJ
Biochem J; 1981 Aug; 197(2):459-64. PubMed ID: 6275834
[TBL] [Abstract][Full Text] [Related]
27. Calmodulin antagonists' binding sites on calmodulin.
Tanaka T; Ohmura T; Hidaka H
Pharmacology; 1983; 26(5):249-57. PubMed ID: 6304789
[TBL] [Abstract][Full Text] [Related]
28. Calmodulin antagonistic action of KS-504a, a novel metabolite of the fungus Mollisia ventosa.
Nakanishi S; Kuroda K; Osawa K; Kase H
Agric Biol Chem; 1990 Oct; 54(10):2697-702. PubMed ID: 1369297
[TBL] [Abstract][Full Text] [Related]
29. The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
Thayer SA; Fairhurst AS
Mol Pharmacol; 1983 Jul; 24(1):6-9. PubMed ID: 6865927
[TBL] [Abstract][Full Text] [Related]
30. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
Santos DL; Lopes MC; Carvalho CM
Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
[TBL] [Abstract][Full Text] [Related]
31. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.
Ahn HS; Crim W; Romano M; Sybertz E; Pitts B
Biochem Pharmacol; 1989 Oct; 38(19):3331-9. PubMed ID: 2554921
[TBL] [Abstract][Full Text] [Related]
32. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
33. Cyclic GMP-gated channels of bovine rod photoreceptors: affinity, density and stoichiometry of Ca(2+)-calmodulin binding sites.
Bauer PJ
J Physiol; 1996 Aug; 494 ( Pt 3)(Pt 3):675-85. PubMed ID: 8865065
[TBL] [Abstract][Full Text] [Related]
34. Trifluoperazine binding to porcine brain calmodulin and skeletal muscle troponin C.
Massom L; Lee H; Jarrett HW
Biochemistry; 1990 Jan; 29(3):671-81. PubMed ID: 2110826
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists.
Sharma RK; Wang JH; Wu Z
J Neurochem; 1997 Aug; 69(2):845-50. PubMed ID: 9231746
[TBL] [Abstract][Full Text] [Related]
36. Benzylisoquinoline compounds inhibit the ability of calmodulin to activate cyclic nucleotide phosphodiesterase.
Hu ZY; Chen SL; Hao ZG; Huang WL; Peng SX
Cell Signal; 1989; 1(2):181-5. PubMed ID: 2561985
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarbox ylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester (CV-159), on rat ischemic brain injury.
Miyazaki H; Tanaka S; Fujii Y; Shimizu K; Nagashima K; Kamibayashi M; Uehara T; Okuma Y; Nomura Y
Life Sci; 1999; 64(10):869-78. PubMed ID: 10096437
[TBL] [Abstract][Full Text] [Related]
38. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
39. Ca2(+)-dependent binding of tamoxifen to calmodulin isolated from bovine brain.
Lopes MC; Vale MG; Carvalho AP
Cancer Res; 1990 May; 50(9):2753-8. PubMed ID: 2139360
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
